GlassScriptPhysician profile
Alejandro Ovalle
NPI 1265466726
$19,215.71
in general payments reported to CMS, 2019-2025
41 companies · $3,460 in 2025
The $3,460 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,432 · 2020: $811 · 2021: $2,827 · 2022: $3,292 · 2023: $4,052 · 2024: $3,341 · 2025: $3,460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,833.60 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $5,597.04 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $2,639.92 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbott Laboratories | $1,874.49 | 2021-2025 | Freestyle Libre 3, Proclaim, Eterna |
| Janssen Pharmaceuticals, INC | $1,254.42 | 2020-2024 | Xarelto |
| Amgen INC. | $977.17 | 2019-2025 | Repatha, Otezla, Evenity |
| Lilly USA, LLC | $937.83 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $767.76 | 2019-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $660.25 | 2021-2025 | |
| Inspire Medical Systems, INC. | $629.18 | 2023-2024 | Inspire |
| Boston Scientific Corporation | $466.23 | 2022-2025 | Wavewriter Alpha Prime 16, Lux-Dx Insertable Cardiac Monitor, Watchman Access System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $359.95 | 2022-2025 | Xifaxan |
| Abbvie INC. | $310.11 | 2020-2025 | |
| Glaxosmithkline, LLC. | $294.30 | 2019-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Medtronic, INC. | $271.50 | 2021-2023 | Resolute Onyx |
| Corcept Therapeutics | $252.97 | 2025 | Korlym |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $230.57 | 2025 | Senza |
| Biohaven Pharmaceuticals, INC. | $205.60 | 2020-2021 | |
| Stryker Corporation | $148.18 | 2021 | |
| Biotissue Holdings INC. | $146.92 | 2021 | |
| Impulse Dynamics (USA) INC. | $127.61 | 2025 | Optimizer |
| Angiodynamics, INC. | $123.24 | 2023 | Auryon Laser System 100-120 Vac |
| Intuitive Surgical, INC. | $121.15 | 2024 | |
| Insulet Corporation | $117.04 | 2024 | Omnipod |
| Rxsight INC | $97.51 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $87.79 | 2019-2022 | |
| Astellas Pharma US INC | $87.38 | 2025 | Veozah |
| Shield Therapeutics INC | $64.51 | 2023-2024 | Accrufer |
| Pfizer INC. | $52.68 | 2023-2025 | |
| Radius Health, INC. | $39.06 | 2022-2025 | Tymlos |
| Sanofi-Aventis U.S. LLC | $38.85 | 2022 | |
| Abiomed | $34.82 | 2025 | |
| Inogen, INC. | $34.78 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Alnylam Pharmaceuticals INC. | $29.36 | 2025 | Amvuttra |
| Novartis Pharmaceuticals Corporation | $25.63 | 2022 | |
| Scpharmaceuticals INC. | $19.47 | 2024 | |
| Dexcom, INC. | $19.23 | 2022 | |
| Allergan, INC. | $18.40 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.32 | 2022 | |
| Redhill Biopharma INC. | $14.64 | 2024 | Talicia |
| Exact Sciences Corporation | $13.98 | 2023 | Cologuard Collection Kit |
| Phathom Pharmaceuticals, INC. | $5.87 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandro Ovalle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.